首页> 外文期刊>Breast Cancer: Targets and Therapy >Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis
【24h】

Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis

机译:肿瘤排出的淋巴结在乳腺癌转移中的区域淋巴结途径

获取原文
           

摘要

Background: During metastasis, tumor cells metastasize from primary tumors to distant organs via the circulatory and the lymphatic systems. There is a plethora of information about metastasis through the circulatory system, however not much information is available about the tumor cells dissemination through the lymphatic system or the lymphatic microenvironment that aids in this process in breast cancer metastasis. Purpose: The study designed to examine the tumor-derived secretome in lymph before reaching the draining lymph nodes. Methods: Using a microsurgical technique, we have collected the lymph in transit from the primary tumor en route to the regional lymph node in animals with metastatic and non-metastatic mammary carcinoma and healthy controls. The lymph samples were subjected to LC-MS/MS analysis, bioinformatics, and pathway analysis. Results: The metastatic tumor-draining lymph before its entry into the closest regional lymph node contain 26 proteins with 175-folds in abundance compared to lymph from non-metastatic tumor-bearing animals. Among these proteins were biliverdin reductase B, heat shock protein, coagulation factor XIII, lymphocytes cytosol protein 1, and aldose reductase. These proteins were not identified in the lymph from healthy animals. Pathways analysis revealed that cadherin-mediated endocytosis, acute phase response, junction signaling, gap junction, VEGF singling, and PI3K/AKT singling pathways are overrepresented in the lymph from metastatic tumor-bearing compared to the lymph from non-metastatic tumor-bearing animals. Among the significantly up-regulated proteins in the lymph from metastatic tumor-bearing animals were proteins that identified in exosomes include heat shock protein, enolase 1 alpha, S100, and biliverdin reductase B. One of the proteins significantly down-regulated in lymph from animals with metastasis is Kininogen, a known metastasis inhibitor protein. Conclusion: Proteins and exosomal proteins in lymph draining a metastatic tumor are different from those in lymph draining non-metastatic tumors, and these proteins involved in pathways that regulate tumor cells migration and invasion.
机译:背景:在转移期间,肿瘤细胞通过循环和淋巴系统将肿瘤细胞从原发性肿瘤转移到远处的器官。通过循环系统存在有关转移的多种信息,然而,没有多少信息通过淋巴系统或淋巴细胞传播,涉及乳腺癌转移的淋巴细胞和淋巴细胞癌。目的:旨在在达到排水淋巴结之前检查淋巴中肿瘤衍生的秘密的研究。方法:采用显微外科技术,我们在具有转移性和非转移性乳腺癌和健康对照的动物中,从原发性肿瘤中收集了从原发性肿瘤的淋巴结到区域淋巴结。淋巴样品进行LC-MS / MS分析,生物信息学和途径分析。结果:与非转移性肿瘤患者的淋巴相比,进入最近区域淋巴结进入最近区域淋巴结前的转移性肿瘤淋巴含有26个蛋白质,与淋巴中有75倍。在这些蛋白质中是胆汁丁蛋白还原酶B,热休克蛋白,凝血因子XIII,淋巴细胞细胞溶胶蛋白1和醛糖还原酶。这些蛋白质未在健康动物的淋巴中鉴定出来。途径分析表明,与非转移性肿瘤患者的淋巴相比,钙粘蛋白介导的内吞作用,急性期响应,结信号,间隙,VEGF单曲和PI3K / AKT单身途径在淋巴中覆盖,从转移性肿瘤的淋巴中叠加。在转移性肿瘤中的淋巴中显着上调的蛋白质是在外泌体中鉴定的蛋白质包括热休克蛋白,烯醇酶1α,S100和Biliverdin还原酶B.其中一种蛋白质在淋巴中显着下调动物含有转移是激动导体,一种已知的转移抑制剂蛋白。结论:淋巴中的蛋白质和外来蛋白质在转移肿瘤中的蛋白质不同于淋巴排出的非转移性肿瘤中的蛋白质,以及调节肿瘤细胞迁移和侵袭的途径中的这些蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号